RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons

Cellular Signalling

Volumn 19, Issue 12, 2007, Pages 2558-2571

  Rodríguez Muñoz, María ^a   de la Torre Madrid, Elena ^a   Gaitán, Gema ^a   Sánchez Blázquez, Pilar ^a   Garzón, Javier ^a  

^a INSTITUTO CAJAL   (Spain)

Author keywords

Desensitization; Morphine; Mu opioid receptor; Nervous tissue; Receptor internalization; Receptor phosphorylation; RGS14 protein

Indexed keywords

BETA ARRESTIN; DIZOCILPINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G PROTEIN COUPLED RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; RGS14 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; ENDOCYTOSIS; IMMUNOPRECIPITATION; INTERNALIZATION; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; SYNAPTOSOME; TAIL FLICK TEST;

AMINO ACID SEQUENCE; ANALGESICS, OPIOID; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; ENDOCYTOSIS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENZYME ACTIVATION; G-PROTEIN-COUPLED RECEPTOR KINASES; GENE SILENCING; HEAT; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOLECULAR SEQUENCE DATA; MORPHINE; NEURONS; OLIGONUCLEOTIDES, ANTISENSE; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY; PHOSPHORYLATION; RECEPTORS, OPIOID, MU; RGS PROTEINS; SERINE; SYNAPTOSOMES; TIME FACTORS;

MUS;

EID: 34948814089     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2007.08.003     Document Type: Article

References (62)

1. Garzón J., Rodríguez-Díaz M., López-Fando A., García-España A., and Sánchez-Blázquez P. Neuropharmacology 42 (2002) 813
2. Pitcher J.A., Freedman N.J., and Lefkowitz R.J. Annu. Rev. Biochem. Allied Res. India 67 (1998) 653
3. Lefkowitz R.J., and Shenoy S.K. Science 308 (2005) 512
4. Arden J.R., Segredo V., Wang Z., Lameh J., and Sadee W. J. Neurochem. 65 (1995) 1636
5. Keith D.E., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Kang L., Evans C.J., and von Zastrow M. J. Biol. Chem. 271 (1996) 19021
6. Keith D.E., Anton B., Murray S.R., Zaki P.A., Chu P.C., Lissin D.V., Monteillet-Agius G., Stewart P.L., Evans C.J., and von Zastrow M. Mol. Pharmacol. 53 (1998) 377
7. Haberstock-Debic H., Wein M., Barrot M., Colago E.E., Rahman Z., Neve R.L., Pickel V.M., Nestler E.J., von Zastrow M., and Svingos A.L. J. Neurosci. 23 (2003) 4324
8. Walwyn W.M., Wei W., Xie C.W., Chiu K., Kieffer B.L., Evans C.J., and Maidment N.T. Neuroscience 142 (2006) 493
9. Rodríguez-Muñoz M., de la Torre-Madrid E., Sánchez-Blázquez P., and Garzón J. Mol. Pain 3 (2007) 19
10. Bohn L.M., Dykstra L.A., Lefkowitz R.J., Caron M.G., and Barak L.S. Mol. Pharmacol. 66 (2004) 106
11. Schulz S., Mayer D., Pfeiffer M., Stumm R., Koch T., and Höllt V. EMBO J. 23 (2004) 3282
12. Whistler J.L., and von Zastrow M. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9914
13. Zhang J., Ferguson S.S., Barak L.S., Bodduluri S.R., Laporte S.A., Law P.Y., and Caron M.G. Proc. Natl. Acad. Sci. U. S. A 95 (1998) 7157
14. Finn A.K., and Whistler J.L. Neuron 32 (2001) 829
15. Koch T., Widera A., Bartzsch K., Schulz S., Brandenburg L.O., Wundrack N., Beyer A., Grecksch G., and Höllt V. Mol. Pharmacol. 67 (2005) 280
16. Bockaert J., Fagni L., Dumuis A., and Marin P. Pharmacol. Ther. 103 (2004) 203
17. Wang Q., Zhao J., Brady A.E., Feng J., Allen P.B., Lefkowitz R.J., Greengard P., and Limbird L.E. Science 304 (2004) 1940
18. Richman J.G., Brady A.E., Wang Q., Hensel J.L., Colbran R.J., and Limbird L.E. J. Biol. Chem. 276 (2001) 15003
19. Yaksh T.L., Yeung J.C., and Rudy T.A. Brain Res. 114 (1976) 83
20. Akil H., Mayer D.J., and Liebeskind J.C. Science 191 (1976) 961
21. Garzón J., Rodríguez-Muñoz M., and Sánchez-Blázquez P. Neuropharmacology 48 (2005) 853
22. Georgoussi Z., Leontiadis L., Mazarakou G., Merkouris M., Hyde K., and Hamm H. Cell. Signal. 18 (2006) 771
23. Ballon D.R., Flanary P.L., Gladue D.P., Konopka J.B., Dohlman H.G., and Thorner J. Cell 126 (2006) 1079
24. Chen S., and Hamm H.E. Dev. Cell 11 (2006) 436
25. Guang W., Wang H., Su T., Weinstein I.B., and Wang J.B. Mol. Pharmacol. 66 (2004) 1285
26. Ajit S.K., Ramineni S., Edris W., Hunt R.A., Hum W.T., Hepler J.R., and Young K.H. Cell. Signal. 19 (2007) 723
27. Martin-McCaffrey L., Willard F.S., Oliveira-dos-Santos A.J., Natale D.R., Snow B.E., Kimple R.J., Pajak A., Watson A.J., Dagnino L., Penninger J.M., Siderovski D.P., and D'Souza S.J. Dev. Cell 7 (2004) 763
28. Kimple R.J., De V.L., Tronchere H., Behe C.I., Morris R.A., Gist F.M., and Siderovski D.P. J. Biol. Chem. 276 (2001) 29275
29. Kimple R.J., Kimple M.E., Betts L., Sondek J., and Siderovski D.P. Nature 416 (2002) 878
30. Shu F.J., Ramineni S., Amyot W., and Hepler J.R. Cell. Signal. 19 (2007) 163
31. Hepler J.R., Cladman W., Ramineni S., Hollinger S., and Chidiac P. Biochemistry 44 (2005) 5495
32. Garzón J., Rodriguez-Muñoz M., López-Fando A., and Sánchez-Blázquez P. J. Biol. Chem. 280 (2005) 8951
33. Rodríguez-Muñoz M., Bermúdez D., Sánchez-Blázquez P., and Garzón J. Neuropsychopharmacology 32 (2007) 842
34. Garzón J., Rodriguez-Muñoz M., López-Fando A., and Sánchez-Blázquez P. Neuropsychopharmacology 30 (2005) 1632
35. Hoffmeister F., and Kronenerg G. In: Mantegazza P., and Piccinini F. (Eds). Methods in Drug Evaluation (1966), North Holland Publishing Company, Amsterdam 270
36. Heinricher M.M., Schouten J.C., and Jobst E.E. Pain 92 (2001) 129
37. Kvam T.M., Baar C., Rakvag T.T., Kaasa S., Krokan H.E., and Skorpen F. J. Mol. Med. 82 (2004) 250
38. Pan Y.X., Xu J., Mahurter L., Bolan E., Xu M., and Pasternak G.W. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 14084
39. Bailey C.P., Kelly E., and Henderson G. Mol. Pharmacol. 66 (2004) 1592
40. El Kouhen R., Burd A.L., Erickson-Herbrandson L.J., Chang C.Y., Law P.Y., and Loh H.H. J. Biol. Chem. 276 (2001) 12774
41. Chavkin C., McLaughlin J.P., and Celver J.P. Mol. Pharmacol. 60 (2001) 20
42. Celver J., Xu M., Jin W., Lowe J., and Chavkin C. Mol. Pharmacol. 65 (2004) 528
43. Cho H., Kozasa T., Takekoshi K., De G.J., and Kehrl J.H. Mol. Pharmacol. 58 (2000) 569
44. Hollinger S., Taylor J.B., Goldman E.H., and Hepler J.R. J. Neurochem. 79 (2001) 941
45. Phillips M.I. Methods in Enzymology: Antisense Technology, Part B Applications (2001), Academic Press, San Diego 314
46. Sánchez-Blázquez P., Rodriguez-Muñoz M., Montero C., and Garzón J. Neuropharmacology 48 (2005) 134
47. Bilsky E.J., Inturrisi C.E., Sadee W., Hruby V.J., and Porreca F. Pain 68 (1996) 229
48. Fan G.H., Wang L.Z., Qiu H.C., Ma L., and Pei G. Mol. Pharmacol. 56 (1999) 39
49. Lu L., Zeng S., Liu D., and Ceng X. Neurosci. Lett. 291 (2000) 191
50. Tang L., Shukla P.K., Wang L.X., and Wang Z.J. J. Pharmacol. Exp. Ther. 317 (2006) 901
51. Trujillo K.A., and Akil H. Science 251 (1991) 85
52. Chen L., and Huang L.Y. Neuron 7 (1991) 319
53. Koch T., Schulz S., Schroder H., Wolf R., Raulf E., and Höllt V. J. Biol. Chem. 273 (1998) 13652
54. Celver J.P., Lowe J., Kovoor A., Gurevich V.V., and Chavkin C. J. Biol. Chem. 276 (2001) 4894
55. Penela P., Ruiz-Gomez A., Castano J.G., and Mayor Jr. F. J. Biol. Chem. 273 (1998) 35238
56. Ferguson S.S., Zhang J., Barak L.S., and Caron M.G. Life Sci. 62 (1998) 1561
57. Lefkowitz R.J., Pitcher J., Krueger K., and Daaka Y. Adv. Pharmacol. 42 (1998) 416
58. Trejo J., Hammes S.R., and Coughlin S.R. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13698
59. Tanowitz M., and von Zastrow M. J. Biol. Chem. 278 (2003) 45978
60. Ferrer-Alcon M., La Harpe R., and García-Sevilla J.A. Brain Res. Mol. Brain Res. 121 (2004) 114
61. Elliott K., Minami N., Kolesnikov Y.A., Pasternak G.W., and Inturrisi C.E. Pain 56 (1994) 69
62. Kow L.M., Commons K.G., Ogawa S., and Pfaff D.W. Brain Res. 935 (2002) 87